03rd week of 2018 patent applcation highlights part 19 |
Patent application number | Title | Published |
20180016253 | Glutarimide Derivatives, Use Thereof, Pharmaceutical Composition Based Thereon and Methods for Producing Glutarimide Derivatives | 2018-01-18 |
20180016254 | Glutarimide Derivatives, Use Thereof, Pharmaceutical Composition Based Thereon and Methods for Producing Glutarimide Derivatives | 2018-01-18 |
20180016255 | Glutarimide Derivatives, Use Thereof, Pharmaceutical Composition Based Thereon and Methods for Producing Glutarimide Derivatives | 2018-01-18 |
20180016256 | Glutarimide Derivatives, Use Thereof, Pharmaceutical Composition Based Thereon and Methods for Producing Glutarimide Derivatives | 2018-01-18 |
20180016257 | Glutarimide Derivatives, Use Thereof, Pharmaceutical Composition Based Thereon and Methods for Producing Glutarimide Derivatives | 2018-01-18 |
20180016258 | 2-(2,4,5-SUBSTITUTED ANILINE) PYRIMIDINE DERIVATIVE, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2018-01-18 |
20180016259 | QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR | 2018-01-18 |
20180016260 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | 2018-01-18 |
20180016261 | NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE | 2018-01-18 |
20180016262 | NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE | 2018-01-18 |
20180016263 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | 2018-01-18 |
20180016264 | SALT FORMS OF 4-CYANO-N-(2-(4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRA- HYDRO-2H-PYRAN-4-YL)PYRIDIN-3-YL)-1H-IMIDAZOLE-2-CARBOXAMIDE | 2018-01-18 |
20180016265 | AMINOESTER DERIVATIVES | 2018-01-18 |
20180016267 | COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | 2018-01-18 |
20180016268 | Novel Flavone Based EGFR Inhibitors and Process for Preparation Thereof | 2018-01-18 |
20180016269 | NOVEL COMPOUNDS AND USES THEREOF | 2018-01-18 |
20180016270 | DIAZA-BENZOFLUORANTHRENE COMPOUNDS | 2018-01-18 |
20180016271 | FLUORINATED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS INHIBITORS OF BROMODOMAIN CONTAINING PROTEINS | 2018-01-18 |
20180016272 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | 2018-01-18 |
20180016273 | 2-(HET)ARYL-SUBSTITUTED FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES | 2018-01-18 |
20180016274 | AUTOTAXIN INHIBITORY COMPOUNDS | 2018-01-18 |
20180016275 | NOVEL DIHYDROPYRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS (GPR84 ANTAGONISTS) | 2018-01-18 |
20180016276 | FLUORINATED 3-(2-OXO-3-(3-ARYLPROPYL)IMIDAZOLIDIN-1-YL)-3-ARYLPROPANOIC ACID DERIVATIVES | 2018-01-18 |
20180016277 | DEUTERATED TIC10 | 2018-01-18 |
20180016278 | Imidazo[1,2-a]quinoxalines and Derivatives Thereof for the Treatment of Cancer | 2018-01-18 |
20180016279 | SUBSTITUTED PYRAZOLYLPYRAZOLE DERIVATIVE AND USE OF SAME AS HERBICIDE | 2018-01-18 |
20180016280 | PYRROLO[1,2-f][1,2,4]TRIAZINES USEFUL FOR TREATING RESPIRATORY SYNCITIAL VIRUS INFECTIONS | 2018-01-18 |
20180016281 | HIV INHIBITING BICYCLIC PYRIMIDINE DERIVATIVES | 2018-01-18 |
20180016282 | INHIBITORS OF HISTONE DEACETYLASE | 2018-01-18 |
20180016283 | SOLID STATE FORMS OF SPIRO-OXINDOLE COMPOUNDS | 2018-01-18 |
20180016284 | NOVEL POLYMORPHS | 2018-01-18 |
20180016285 | Boron-Containing Small Molecules | 2018-01-18 |
20180016286 | PROCESS FOR PREPARING SILOXANOLS FROM METAL SALTS OF SILANOLS | 2018-01-18 |
20180016287 | METHOD OF STABILIZING IMINO-FUNCTIONAL SILANE | 2018-01-18 |
20180016288 | COMPOUNDS OF PHOSPHINANES AND AZAPHOSPHINANES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2018-01-18 |
20180016289 | REDOX-SENSITIVE VESICLES | 2018-01-18 |
20180016290 | PROCESS FOR THE PREPARATION OF SGLT INHIBITOR COMPOUNDS | 2018-01-18 |
20180016291 | Rebaudioside Analogs | 2018-01-18 |
20180016292 | PROCESS FOR THE PREPARATION OF DIOSMIN | 2018-01-18 |
20180016293 | Oligonucleotide Compositions and Methods of Making the Same | 2018-01-18 |
20180016294 | Oligonucleotide Compositions and Methods of Making the Same | 2018-01-18 |
20180016295 | TGR5 Modulators and Methods of Use Thereof | 2018-01-18 |
20180016296 | METHOD FOR FULLY AUTOMATED SYNTHESIS OF 16Beta-18F-FLUORO-5Alpha-DIHYDROTESTOSTERONE (18F-FDHT) | 2018-01-18 |
20180016297 | CRYSTALLINE FORMS OF S-[4-(3-FLUORO-3-METHYLBUTYRYLOXY)BUT-2-YNYL] 6-ALPHA,9-ALPHA-DIFLUORO-17-ALPHA-(FURAN-2-YL)CARBONYLOXY-11-BETA-HYDROXY- -16-ALPHA-METHYL-3-OXOANDROSTA-1,4-DIENE-17-BETA-CARBOTHIOATE | 2018-01-18 |
20180016298 | TERPENOID DERIVATIVES | 2018-01-18 |
20180016299 | METHODS FOR MAKING ARRAYS FOR HIGH THROUGHPUT PROTEOMICS | 2018-01-18 |
20180016300 | COMPOUNDS, LINKER-DRUGS AND LIGAND-DRUG CONJUGATES | 2018-01-18 |
20180016301 | Synthesis of Beta-Arrestin Effectors | 2018-01-18 |
20180016302 | Peptides for Treating Cancer | 2018-01-18 |
20180016303 | BK CHANNEL-MODULATING PEPTIDES AND THEIR USE | 2018-01-18 |
20180016304 | SELF-ASSEMBLING ULTRASHORT ALIPHATIC DEPSIPEPTIDES FOR BIOMEDICAL APPLICATIONS | 2018-01-18 |
20180016305 | DAGRS: Directed Antigonists to Cancer Cell Growth Signals | 2018-01-18 |
20180016306 | MUTANT IMMUNOGLOBULIN K CHAIN VARIABLE REGION-BINDING PEPTIDE | 2018-01-18 |
20180016307 | GRIFFITHSIN MUTANTS | 2018-01-18 |
20180016308 | HUMAN ALPHA-DEFENSIN 5 VARIANT AND USES THEREOF | 2018-01-18 |
20180016309 | NOVEL BT TOXIN RECEPTORS AND METHODS OF USE | 2018-01-18 |
20180016310 | FUSION PROTEINS OF SUPERFOLDER GREEN FLUORESCENT PROTEIN AND USE THEREOF | 2018-01-18 |
20180016311 | PEPTIDES AND COMPOSITIONS FOR PREVENTION OF CELL ADHESION AND METHODS OF USING SAME | 2018-01-18 |
20180016312 | NOVEL PROTEINS SPECIFIC FOR ANGIOGENESIS | 2018-01-18 |
20180016313 | MODIFIED DKK2 PROTEIN, NUCLEIC ACID ENCODING THE SAME, PREPARATION METHOD THEREOF, AND USE THEREOF | 2018-01-18 |
20180016314 | TREATMENT OF DISEASE VIA TRANSCRIPTION FACTOR MODULATION | 2018-01-18 |
20180016315 | ERYTHROPOIETIN-DERIVED SHORT PEPTIDE AND ITS MIMICS AS IMMUNO/INFLAMMATORY MODULATORS | 2018-01-18 |
20180016316 | SUPERKINES AND SYNTHEKINES: REPURPOSED CYTOKINES WITH NEW AND ENHANCED SIGNALING ACTIVITIES | 2018-01-18 |
20180016317 | COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES AND DISORDERS | 2018-01-18 |
20180016318 | Novel Fatty Acid Modified Urocortin-2 Analogs for the Treatment of Diabetes and Chronic Kidney Disease | 2018-01-18 |
20180016319 | Acylated Glucagon Analogues | 2018-01-18 |
20180016320 | METHODS AND COMPOSITIONS FOR MODULATING TOSO ACTIVITY | 2018-01-18 |
20180016321 | METHOD OF PRODUCING COLLAGEN FROM HYDROLYZED EGG MEMBRANE | 2018-01-18 |
20180016322 | ANTIBODIES SPECIFIC TO GLYCOPROTEIN (GP) OF EBOLAVIRUS AND USES FOR THE TREATMENT AND DIAGNOSIS OF EBOLA VIRUS INFECTION | 2018-01-18 |
20180016323 | BINDING MOLECULES DIRECTED AGAINST INFLUENZA HEMAGGLUTININ AND USES THEREOF | 2018-01-18 |
20180016324 | Anti-Zika Virus Antibodies and Methods of Use | 2018-01-18 |
20180016325 | ANTI-WALL TEICHOIC ANTIBODIES AND CONJUGATES | 2018-01-18 |
20180016326 | ANTIBODIES THAT BIND PEPTIDOGLYCAN RECOGNITION PROTEIN 1 | 2018-01-18 |
20180016327 | A Combination of Two or More Anti-C5 Antibodies and Methods of Use | 2018-01-18 |
20180016328 | ANTI-TAU CONSTRUCTS | 2018-01-18 |
20180016329 | Humanized Antibodies That Recognize Alpha-Synuclein | 2018-01-18 |
20180016330 | Antibodies Specific for Hyperphosphorylated Tau and Methods of Use Thereof | 2018-01-18 |
20180016331 | METHODS OF PREVENTING OR TREATING PAIN USING ANTI-NGF ANTIBODIES | 2018-01-18 |
20180016332 | COMPOSITIONS AND METHODS FOR GROWTH FACTOR MODULATION | 2018-01-18 |
20180016333 | PHARMACEUTICAL FORMULATIONS FOR ANTI-TNF-ALPHA ANTIBODIES | 2018-01-18 |
20180016334 | FCRN ANTIBODIES AND METHODS OF USE THEREOF | 2018-01-18 |
20180016335 | SIGNALLING SYSTEM | 2018-01-18 |
20180016336 | ANTIBODIES AGAINST TIM3 AND USES THEREOF | 2018-01-18 |
20180016337 | CAR IMMUNE CELLS TO TREAT CANCERS | 2018-01-18 |
20180016338 | ANTI CEACAM1 ANTIBODIES AND METHODS OF USING SAME | 2018-01-18 |
20180016339 | SOLUBLE MIC NEUTRALIZING MONOCLONAL ANTIBODY FOR TREATING CANCER | 2018-01-18 |
20180016340 | Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (IGF-1) | 2018-01-18 |
20180016341 | Antibody Therapeutics That Bind CD123 | 2018-01-18 |
20180016342 | INTERLEUKIN-6 RECEPTOR BINDING POLYPEPTIDES | 2018-01-18 |
20180016343 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST | 2018-01-18 |
20180016344 | Multivalent Molecules Comprising DR5-Binding Domains | 2018-01-18 |
20180016345 | LIGHT INHIBITORS FOR SCLERODERMA AND SKIN FIBROTIC DISEASE TREATMENT | 2018-01-18 |
20180016346 | BISPECIFIC ANTIBODY BINDING TO TRAILR2 AND PSMA | 2018-01-18 |
20180016347 | STABLE HETERODIMERIC ANTIBODY DESIGN WITH MUTATIONS IN THE Fc DOMAIN | 2018-01-18 |
20180016348 | HUMAN NEUTRALIZING ANTIBODIES BINDING TO INFLUENZA NEURAMINIDASE | 2018-01-18 |
20180016349 | CONJUGATED ANTI-CD38 ANTIBODIES | 2018-01-18 |
20180016350 | METHOD FOR DECREASING IMMUNOGENICITY | 2018-01-18 |
20180016351 | ANTIBODIES COMPRISING SEQUENCES FROM CAMELIDAE TO HIGHLY CONSERVED TARGETS | 2018-01-18 |
20180016352 | TARGETING CONSTRUCTS FOR DELIVERY OF PAYLOADS | 2018-01-18 |
20180016353 | METHOD FOR OBTAINING HIGH-YIELD, STABLE EXPRESSION CELL CLONES AND ANTIBODY MOLECULES OBTAINED THEREBY | 2018-01-18 |